Bruxelles, COST Association premise - 7 July 2025

Integrating ecotoxcity in early-stage drug development - Agenda

Agenda_full

Summary of the workshop

Moving from the 7 July 2025 Brussels, meeting where the 1st stakeholders meeting on "Integrating Ecotoxicity in Early stage Drug development" took place, OneHealthdrugs COST Action is now organizing the 2nd stakeholder meeting.

The 1st meeting joined OneHealthdrugs COST Action members, Pharma company and regulatory experts, United Nations representatives and environmental science experts. The Team after 1 Day discussion reached an agreements and promoted the following action points:

Key strategic shifts identified:
·      From Passive to Active: We must transform pharmacovigilance from passive reporting to active, science-based monitoring to trace and mitigate pollution sources effectively.
·      Prioritizing Alternatives: It is time to champion biological controls and vaccines over the intensive, often oversight-free use of chemical treatments by the agricultural sector (pesticides).
·      Closing the Education Gap: Environmental impact and drug resistance markers must become core pillars of European veterinary curricula.
·      Updating the Playbook: We are calling for modern technologies and ecotoxicity data to be integrated into OECD and regulatory guidelines from the earliest stages of drug development.
- Considering sustainability as an health strategy. Let’s build a pharmaceutical pipeline that protects both the patient and the planet.

Follow us in the new appointment planned for March 6th, 2026 in Brussels!

hashtag#OneHealth hashtag#Veterinarydrugs hashtag#Sustainability hashtag#PharmaInnovation hashtag#EnvironmentalPolicy hashtag#GreenScience
 

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Wioleta Walentowska
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi